Form 8-K - Current report:
SEC Accession No. 0001683168-25-003163
Filing Date
2025-05-06
Accepted
2025-05-06 08:09:06
Documents
15
Period of Report
2025-05-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K actuate_8k.htm   iXBRL 8-K 34586
2 PRESS RELEASE OF ACTUATE THERAPEUTICS, INC. DATED MAY 6, 2025 actuate_ex9901.htm EX-99.1 19477
6 GRAPHIC actuatelogo.jpg GRAPHIC 24191
  Complete submission text file 0001683168-25-003163.txt   274733

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE actu-20250506.xsd EX-101.SCH 3105
4 XBRL LABEL FILE actu-20250506_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE actu-20250506_pre.xml EX-101.PRE 24186
17 EXTRACTED XBRL INSTANCE DOCUMENT actuate_8k_htm.xml XML 3803
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Filer) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42139 | Film No.: 25915331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)